O1‐01‐03: Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study-Reference-Cited by-同舟云学术

O1‐01‐03: Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study

Published:2009-07 Issue:4S_Part_3 Volume:5 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Doraiswamy P Murali¹,Farmer Mildred²,Holub Richard³,Johnson Keith⁴,Reiman Eric M.⁵,Sadowsky Carl⁶,Safirstein Beth⁷,Spicer Kenneth⁸,Carpenter Alan⁹,Clark Christopher M.⁹,Joshi Abhinay⁹,Veeraraj Catherine⁹,Pontecorvo Michael J.⁹,Skovronsky Daniel⁹

Affiliation:

1. Duke University Medical CenterDurhamNCUSA

2. Meridien ResearchSt. PetersburgFLUSA

3. Neurological AssociatesAlbanyNYUSA

4. Massachusetts General HospitalBostonMAUSA

5. Banner Alzheimer's InstitutePhoenixAZUSA

6. Premier ResearchWest Palm BeachFLUSA

7. MD ClinicalHallandale BeachFLUSA

8. Medical University of South CarolinaCharlestonSCUSA

9. Avid RadiopharmaceuticalsPhiladelphiaPAUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2009.05.189

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain imaging in the study of Alzheimer's disease;NeuroImage;2012-06

2. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative;NeuroImage;2010-06

3. Amyloid PET Ligands for Dementia;PET Clinics;2010-01